ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
Breast Cancer Research and Treatment
◽
10.1007/s10549-009-0489-8
◽
2009
◽
Vol 120
(3)
◽
pp. 727-736
◽
Cited By ~ 46
Author(s):
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Postmenopausal Women
◽
Menopausal Hormone Therapy
Download Full-text
Related Documents
Cited By
References
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
Breast Cancer Research and Treatment
◽
10.1007/s10549-009-0407-0
◽
2009
◽
Vol 119
(2)
◽
pp. 463-474
◽
Cited By ~ 54
Author(s):
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Phase I
◽
Hormone Therapy
◽
Postmenopausal Women
◽
Genetic Polymorphisms
◽
Phase Ii
◽
Menopausal Hormone Therapy
◽
Phase Ii Enzymes
Download Full-text
Erratum to: Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
Breast Cancer Research and Treatment
◽
10.1007/s10549-009-0529-4
◽
2009
◽
Vol 119
(2)
◽
pp. 475-475
Author(s):
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Phase I
◽
Hormone Therapy
◽
Postmenopausal Women
◽
Genetic Polymorphisms
◽
Phase Ii
◽
Menopausal Hormone Therapy
◽
Phase Ii Enzymes
Download Full-text
Berlin, 09.09.2019 – Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) zur Lancet-Studie „Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence“ (29. August 2019; doi:10.1016/S0140-6736(19)31709-X)
Geburtshilfe und Frauenheilkunde
◽
10.1055/a-1060-5694
◽
2019
◽
Vol 79
(12)
◽
pp. 1259-1260
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Meta Analysis
◽
Menopausal Hormone Therapy
◽
Epidemiological Evidence
◽
Individual Participant
Download Full-text
BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020
Post Reproductive Health
◽
10.1177/2053369120983154
◽
2021
◽
pp. 205336912098315
Author(s):
Haitham Hamoda
◽
Susan R Davis
◽
Antonio Cano
◽
Edward Morris
◽
Sonia Davison
◽
...
Keyword(s):
Breast Cancer
◽
Risk Assessment
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Menopausal Hormone Therapy
◽
Joint Statement
◽
Pharmacovigilance Risk Assessment Committee
◽
Assessment Committee
Download Full-text
Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) zur Lancet-Studie „Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence“ (29. August 2019; doi:10.1016/S0140-6736(19)31709-X)
Senologie - Zeitschrift für Mammadiagnostik und -therapie
◽
10.1055/a-1102-4436
◽
2021
◽
Vol 18
(01)
◽
pp. 23-24
Author(s):
Günter Emons
◽
Anton J. Scharl
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Menopausal Hormone Therapy
◽
Epidemiological Evidence
◽
Individual Participant
Download Full-text
Kommentar zur Hormonersatztherapie – Ergänzung zur DGGG-Stellungnahme zur Lancet-Studie „Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metanalysis of the worldwide epidemiological evidence“ (29. August 2019)
Senologie - Zeitschrift für Mammadiagnostik und -therapie
◽
10.1055/a-1342-5058
◽
2021
◽
Vol 18
(01)
◽
pp. 25-26
Author(s):
Christian Albring
◽
Georg Döhmen
◽
Ludwig Kiesel
◽
Joseph Neulen
◽
Katrin Schaudig
◽
...
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Menopausal Hormone Therapy
◽
Epidemiological Evidence
◽
Individual Participant
Download Full-text
Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study
International Journal of Cancer
◽
10.1002/ijc.29942
◽
2015
◽
Vol 138
(8)
◽
pp. 1905-1914
◽
Cited By ~ 6
Author(s):
Usha Salagame
◽
Emily Banks
◽
Freddy Sitas
◽
Karen Canfell
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
New South
◽
New South Wales
◽
Menopausal Hormone Therapy
◽
South Wales
Download Full-text
Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life
European Journal of Epidemiology
◽
10.1007/s10654-018-0431-7
◽
2018
◽
Vol 34
(3)
◽
pp. 267-278
Author(s):
Marie Søfteland Sandvei
◽
Lars J. Vatten
◽
Elisabeth Krefting Bjelland
◽
Anne Eskild
◽
Solveig Hofvind
◽
...
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Body Mass
◽
Effect Modification
◽
Menopausal Hormone Therapy
◽
Risk Effect
Download Full-text
Abstract 655: Menopausal hormone therapy and breast cancer risk: The CECILE Study
10.1158/1538-7445.am2012-655
◽
2012
◽
Author(s):
Emilie Cordina-Duverger
◽
Thérèse Truong
◽
Antoinette Anger
◽
Claire Mulot
◽
Patrick Arveux
◽
...
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
Menopausal Hormone Therapy
Download Full-text
Abstract 2285: Menopausal hormone therapy (MHT) use and breast cancer risk by receptor subtypes: results from the New South Wales Cancer Lifestyle and EvAluation of Risk (CLEAR) study
10.1158/1538-7445.am2017-2285
◽
2017
◽
Author(s):
Usha G. Salagame
◽
Emily Banks
◽
Dianne O’Connell
◽
Sam Egger
◽
Karen Canfell
Keyword(s):
Breast Cancer
◽
Breast Cancer Risk
◽
Cancer Risk
◽
Hormone Therapy
◽
New South
◽
New South Wales
◽
Menopausal Hormone Therapy
◽
Receptor Subtypes
◽
South Wales
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close